Logo image of ATCH

ATLASCLEAR HOLDINGS INC (ATCH) Stock Fundamental Analysis

NYSEARCA:ATCH - NYSE Arca - US1287452056 - Common Stock - Currency: USD

0.1897  0 (-1.2%)

After market: 0.1871 0 (-1.37%)

Fundamental Rating

1

Overall ATCH gets a fundamental rating of 1 out of 10. We evaluated ATCH against 233 industry peers in the Capital Markets industry. ATCH has a bad profitability rating. Also its financial health evaluation is rather negative. ATCH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ATCH had positive earnings in the past year.
ATCH had a negative operating cash flow in the past year.
ATCH Yearly Net Income VS EBIT VS OCF VS FCFATCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M 10M

1.2 Ratios

The Return On Assets of ATCH (1.43%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 1.84%, ATCH is doing worse than 69.96% of the companies in the same industry.
Industry RankSector Rank
ROA 1.43%
ROE 1.84%
ROIC N/A
ROA(3y)1.34%
ROA(5y)N/A
ROE(3y)1.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATCH Yearly ROA, ROE, ROICATCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -10 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATCH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATCH Yearly Profit, Operating, Gross MarginsATCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ATCH has less shares outstanding
ATCH has a worse debt/assets ratio than last year.
ATCH Yearly Shares OutstandingATCH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M 25M
ATCH Yearly Total Debt VS Total AssetsATCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

ATCH has an Altman-Z score of -0.55. This is a bad value and indicates that ATCH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.55, ATCH is doing worse than 81.97% of the companies in the same industry.
ATCH has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ATCH has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. ATCH outperforms 84.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.55
ROIC/WACCN/A
WACCN/A
ATCH Yearly LT Debt VS Equity VS FCFATCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

ATCH has a Current Ratio of 0.06. This is a bad value and indicates that ATCH is not financially healthy enough and could expect problems in meeting its short term obligations.
ATCH has a Current ratio of 0.06. This is amonst the worse of the industry: ATCH underperforms 94.85% of its industry peers.
A Quick Ratio of 0.06 indicates that ATCH may have some problems paying its short term obligations.
With a Quick ratio value of 0.06, ATCH is not doing good in the industry: 94.85% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
ATCH Yearly Current Assets VS Current LiabilitesATCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

The earnings per share for ATCH have decreased strongly by -83.95% in the last year.
EPS 1Y (TTM)-83.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.71 indicates a rather cheap valuation of ATCH.
Compared to the rest of the industry, the Price/Earnings ratio of ATCH indicates a rather cheap valuation: ATCH is cheaper than 96.57% of the companies listed in the same industry.
ATCH is valuated cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.71
Fwd PE N/A
ATCH Price Earnings VS Forward Price EarningsATCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATCH Per share dataATCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ATCH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATLASCLEAR HOLDINGS INC

NYSEARCA:ATCH (7/1/2025, 5:51:51 PM)

After market: 0.1871 0 (-1.37%)

0.1897

0 (-1.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-09 2024-08-09
Earnings (Next)N/A N/A
Inst Owners1.7%
Inst Owner Change-63.12%
Ins Owners0.08%
Ins Owner Change0%
Market Cap2.96M
AnalystsN/A
Price TargetN/A
Short Float %2.8%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.71
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB 0.07
EV/EBITDA N/A
EPS(TTM)0.07
EY36.9%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0
BVpS2.76
TBVpS2.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.43%
ROE 1.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.34%
ROA(5y)N/A
ROE(3y)1.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -0.55
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-67.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.84%
OCF growth 3YN/A
OCF growth 5YN/A